China SXT Pharmaceuticals, Inc. (SXTC)
Nasdaq: SXTC · CIK 0001723980 · United States
Every official China SXT Pharmaceuticals, Inc. filing in one place: annual reports, quarterly results, current reports,
proxy statements, shareholding and announcements, straight from the regulator. Free to search.
Open SXTC filings
China SXT Pharmaceuticals, Inc. documents
- China SXT Pharmaceuticals, Inc. 10-K 2026SXTC 10-K 2026: annual report for fiscal 2026
- China SXT Pharmaceuticals, Inc. 10-K 2025SXTC 10-K 2025: annual report for fiscal 2025
- China SXT Pharmaceuticals, Inc. 10-K 2024SXTC 10-K 2024: annual report for fiscal 2024
- China SXT Pharmaceuticals, Inc. 10-K 2023SXTC 10-K 2023: annual report for fiscal 2023
- China SXT Pharmaceuticals, Inc. 10-K 2022SXTC 10-K 2022: annual report for fiscal 2022
- China SXT Pharmaceuticals, Inc. 10-Q 2026SXTC 10-Q 2026: quarterly report for fiscal 2026
- China SXT Pharmaceuticals, Inc. 10-Q 2025SXTC 10-Q 2025: quarterly report for fiscal 2025
- China SXT Pharmaceuticals, Inc. 10-Q 2024SXTC 10-Q 2024: quarterly report for fiscal 2024
- China SXT Pharmaceuticals, Inc. 10-Q 2023SXTC 10-Q 2023: quarterly report for fiscal 2023
- China SXT Pharmaceuticals, Inc. 10-Q 2022SXTC 10-Q 2022: quarterly report for fiscal 2022
- China SXT Pharmaceuticals, Inc. 8-K 2026SXTC 8-K 2026: current report for fiscal 2026
- China SXT Pharmaceuticals, Inc. 8-K 2025SXTC 8-K 2025: current report for fiscal 2025
- China SXT Pharmaceuticals, Inc. 8-K 2024SXTC 8-K 2024: current report for fiscal 2024
- China SXT Pharmaceuticals, Inc. 8-K 2023SXTC 8-K 2023: current report for fiscal 2023
- China SXT Pharmaceuticals, Inc. 8-K 2022SXTC 8-K 2022: current report for fiscal 2022
- China SXT Pharmaceuticals, Inc. DEF 14A 2026SXTC DEF 14A 2026: proxy statement for fiscal 2026
- China SXT Pharmaceuticals, Inc. DEF 14A 2025SXTC DEF 14A 2025: proxy statement for fiscal 2025
- China SXT Pharmaceuticals, Inc. DEF 14A 2024SXTC DEF 14A 2024: proxy statement for fiscal 2024
- China SXT Pharmaceuticals, Inc. DEF 14A 2023SXTC DEF 14A 2023: proxy statement for fiscal 2023
- China SXT Pharmaceuticals, Inc. DEF 14A 2022SXTC DEF 14A 2022: proxy statement for fiscal 2022
- China SXT Pharmaceuticals, Inc. Form 4 2026SXTC Form 4 2026: insider trading filing for fiscal 2026
- China SXT Pharmaceuticals, Inc. Form 4 2025SXTC Form 4 2025: insider trading filing for fiscal 2025
- China SXT Pharmaceuticals, Inc. Form 4 2024SXTC Form 4 2024: insider trading filing for fiscal 2024
- China SXT Pharmaceuticals, Inc. Form 4 2023SXTC Form 4 2023: insider trading filing for fiscal 2023
- China SXT Pharmaceuticals, Inc. Form 4 2022SXTC Form 4 2022: insider trading filing for fiscal 2022
- China SXT Pharmaceuticals, Inc. S-1 2026SXTC S-1 2026: registration statement for fiscal 2026
- China SXT Pharmaceuticals, Inc. S-1 2025SXTC S-1 2025: registration statement for fiscal 2025
- China SXT Pharmaceuticals, Inc. S-1 2024SXTC S-1 2024: registration statement for fiscal 2024
- China SXT Pharmaceuticals, Inc. S-1 2023SXTC S-1 2023: registration statement for fiscal 2023
- China SXT Pharmaceuticals, Inc. S-1 2022SXTC S-1 2022: registration statement for fiscal 2022
- China SXT Pharmaceuticals, Inc. 13F 2026SXTC 13F 2026: institutional holdings for fiscal 2026
- China SXT Pharmaceuticals, Inc. 13F 2025SXTC 13F 2025: institutional holdings for fiscal 2025
- China SXT Pharmaceuticals, Inc. 13F 2024SXTC 13F 2024: institutional holdings for fiscal 2024
- China SXT Pharmaceuticals, Inc. 13F 2023SXTC 13F 2023: institutional holdings for fiscal 2023
- China SXT Pharmaceuticals, Inc. 13F 2022SXTC 13F 2022: institutional holdings for fiscal 2022
More companies